Cardiovascular diagnosis and therapy最新文献

筛选
英文 中文
New look at the power of zero coronary artery calcium (CAC) in Asian population: a systemic review and meta-analysis. 亚洲人冠状动脉钙化(CAC)零功率新观察:系统回顾和荟萃分析。
IF 2.1 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-06-30 Epub Date: 2024-05-30 DOI: 10.21037/cdt-23-474
Chien-Liang Chen, Yun-Ju Wu, Shu-Ching Yang, Fu-Zong Wu
{"title":"New look at the power of zero coronary artery calcium (CAC) in Asian population: a systemic review and meta-analysis.","authors":"Chien-Liang Chen, Yun-Ju Wu, Shu-Ching Yang, Fu-Zong Wu","doi":"10.21037/cdt-23-474","DOIUrl":"10.21037/cdt-23-474","url":null,"abstract":"<p><strong>Background: </strong>Numerous studies have validated a 5-year warranty period for heart health in Western populations with a coronary artery calcium (CAC) score of zero. While the calcium score is a crucial cardiovascular risk indicator, its interpretation in Asian populations remains unclear. This meta-analysis aimed to clarify the uncertainty surrounding the prevalence, warranty period, and prognostic implications of zero CAC scores in Asian populations. It also examined the impact of sex on subclinical CAC progression. While the calcium score is a crucial cardiovascular risk indicator, its interpretation in Asian populations remains unclear. The study aimed to shed light on these issues by exploring the specificities of subclinical CAC progression in the Asian context.</p><p><strong>Methods: </strong>Our systematic literature search, from the study's inception to October 2023, targeted studies on subclinical CAC progression in the Asian population with a zero CAC score. We searched the Cochrane Library, and PubMed. The search terms included \"zero score\", \"coronary calcification\", \"zero CAC score\", and \"CAC scan\".</p><p><strong>Results: </strong>We evaluated seven published studies through a meta-analysis and assessed the risk of bias using the Newcastle-Ottawa Scale (NOS). In this meta-analysis of three observational studies addressing zero CAC prevalence (n=7,661), the pooled prevalence of zero CAC scores in the Asian population was 18.2% [95% confidence interval (CI): 12.5-25.9%]. A significant difference in follow-up warranty period was observed between the CAC zero group and subclinical CAC progression group (mean difference, 1.26 years; 95% CI: 0.94-1.58; P<0.001). Furthermore, the conversion rate of subclinical CAC progression differed significantly between males and females (risk ratio, 2.37; 95% CI: 1.98-2.84; P<0.001). Analysis of four studies revealed a notable discrepancy in the major adverse cardiovascular event (MACE) rate between the CAC (-) and CAC (+) groups (risk ratio, 4.78; 95% CI: 2.21-10.36; P<0.001).</p><p><strong>Conclusions: </strong>The meta-analysis of zero CAC scores in Asian populations suggested an 18.2% prevalence. A 5-year warranty period was noted, with heightened subclinical CAC progression likelihood after this duration. Additionally, sex-based differences were observed in subclinical CAC progression rates. These findings will provide clinical cardiovascular risk stratification for guiding gender-specific clinical decision-making in asymptomatic in Asian individuals.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11223936/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of chimney technique and single-branched stent graft in a cohort of patients with type B aortic dissections: a retrospective cohort study. 在一组 B 型主动脉夹层患者中比较烟囱技术和单支支架移植物:一项回顾性队列研究。
IF 2.1 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-06-30 Epub Date: 2024-06-17 DOI: 10.21037/cdt-23-449
Yue Xing, Zhengrong Zhu, Lan Zou, Jiayu Wu, Guojian Xu, Yiding Xu, Zhijian He, Jianqiang Cao, Canhua Luo
{"title":"Comparison of chimney technique and single-branched stent graft in a cohort of patients with type B aortic dissections: a retrospective cohort study.","authors":"Yue Xing, Zhengrong Zhu, Lan Zou, Jiayu Wu, Guojian Xu, Yiding Xu, Zhijian He, Jianqiang Cao, Canhua Luo","doi":"10.21037/cdt-23-449","DOIUrl":"10.21037/cdt-23-449","url":null,"abstract":"<p><strong>Background: </strong>Single-branched stent grafts and the chimney technique are widely used in the treatment of type B aortic dissection (TBAD). The main objective of this study was to compare the outcomes of single-branched stent grafts and the chimney technique in the treatment of TBAD.</p><p><strong>Methods: </strong>From January 2019 to December 2021, the retrospective cohort study contained a cohort of 91 patients with TBAD undergoing thoracic endovascular aortic repair (TEVAR) using single-branched stent grafts and the chimney technique. Group A included 55 patients treated with single-branched covered stents, and Group B included 36 patients treated with the chimney technique. We compared the effects of the procedures on peri-/post-operative outcomes between the two groups. The primary endpoint is clinical death, and the secondary endpoints include the patency of branch stents, the incidence of cerebral infarction, false lumen thrombosis, and the proportion of paraplegia.</p><p><strong>Results: </strong>For the baseline data, the two groups of patients show no differences in terms of age, gender, and associated symptoms. All procedures were successfully performed in both groups. The median follow-up period was 17.6 months (range, 10-34 months). During TEVAR, 5 (9.1%) type I endoleaks occurred in group A, and 11 (30.6%) occurred in group B (P<0.05). During follow-up, there were 2 cases (3.6%) of paraplegia and 1 case (1.8%) of cerebral infarction in Group A, while Group B had 1 case (2.8%) of paraplegia. Three patients in group B reported retrograde type A aortic dissection (RTAD), and 1 of them died (2.8%); however, there were no RTAD cases in group A. Complete thrombosis of the false lumen in the thoracic aorta was observed in 45.5% (25/55) of patients in group A and in 41.7% (15/36) in group B (P=0.72). No significant difference in the thrombosis-volume ratio in the whole false lumen was found during follow-up between group A (81.0%±2.9%) and group B (81.8%±2.6%; P=0.23).</p><p><strong>Conclusions: </strong>Branched stent grafts can be used in cases with insufficient proximal landing zones and reduce the occurrence of type 1 endoleak compared to the chimney technique. This may help to prevent RTAD. Further research, including more cases and longer follow-up periods, is needed to substantiate these results.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11223938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol and rationale of the Australian multicentre registry for serial cardiac computed tomography angiography (ARISTOCRAT): a prospective observational study of the natural history of pericoronary adipose tissue attenuation and radiomics. 澳大利亚连续心脏计算机断层扫描血管造影多中心登记(ARISTOCRAT)的协议和原理:冠状动脉周围脂肪组织衰减和放射组学自然史的前瞻性观察研究。
IF 2.1 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-06-30 Epub Date: 2024-06-27 DOI: 10.21037/cdt-23-392
Kevin Cheng, Andrew Lin, Peter J Psaltis, Adil Rajwani, Angus Baumann, Nicholas Brett, Nadarajah Kangaharan, James Otton, Stephen J Nicholls, Damini Dey, Dennis T L Wong
{"title":"Protocol and rationale of the Australian multicentre registry for serial cardiac computed tomography angiography (ARISTOCRAT): a prospective observational study of the natural history of pericoronary adipose tissue attenuation and radiomics.","authors":"Kevin Cheng, Andrew Lin, Peter J Psaltis, Adil Rajwani, Angus Baumann, Nicholas Brett, Nadarajah Kangaharan, James Otton, Stephen J Nicholls, Damini Dey, Dennis T L Wong","doi":"10.21037/cdt-23-392","DOIUrl":"10.21037/cdt-23-392","url":null,"abstract":"<p><strong>Background: </strong>Vascular inflammation plays a crucial role in the development of atherosclerosis and atherosclerotic plaque rupture resulting in acute coronary syndrome (ACS). Pericoronary adipose tissue (PCAT) attenuation quantified from routine coronary computed tomography angiography (CCTA) has emerged as a promising non-invasive imaging biomarker of coronary inflammation. However, a detailed understanding of the natural history of PCAT attenuation is required before it can be used as a surrogate endpoint in trials of novel therapies targeting coronary inflammation. This article aims to explore the natural history of PCAT attenuation and its association with changes in plaque characteristics.</p><p><strong>Methods: </strong>The Australian natuRal hISTOry of periCoronary adipose tissue attenuation, RAdiomics and plaque by computed Tomographic angiography (ARISTOCRAT) registry is a multi-centre observational registry enrolling patients undergoing clinically indicated serial CCTA in 9 centres across Australia. CCTA scan parameters will be matched across serial scans. Quantitative analysis of plaque and PCAT will be performed using semiautomated software.</p><p><strong>Discussion: </strong>The primary endpoint is to explore temporal changes in patient-level and lesion-level PCAT attenuation by CCTA and their associations with changes in plaque characteristics. Secondary endpoints include evaluating: (I) impact of statin therapy on PCAT attenuation and plaque characteristics; and (II) changes in PCAT attenuation and plaque characteristics in specific subgroups according to sex and risk factors. ARISTOCRAT will further our understanding of the natural history of PCAT attenuation and its association with changes in plaque characteristics.</p><p><strong>Trial registration: </strong>This study has been prospectively registered with the Australia and New Zealand Clinical Trials Registry (ACTRN12621001018808).</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.1,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11223934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease. 下一代测序的多国经验:识别转甲状腺素心脏淀粉样变性和法布里病的机会。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-03-18 DOI: 10.21037/cdt-23-191
Sandra Marques E Silva, Andrea Virginia Ferreira Chaves, Murillo Antunes, Juan Pablo Costabel, Armando Alves da Fonseca, Adriana Furtado, Juan Esteban Gomez-Mesa, Francisco Javier Marin Gutiérrez, Oren Caspi, Irina Maksimova, Manish Maski, Cecilia Micheletti, José Luiz Barros Pena, Márcia Gonçalves Ribeiro, Maria Juliana Rodríguez-González, Omac Tufekcioglu, Huseyin Onay
{"title":"Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease.","authors":"Sandra Marques E Silva, Andrea Virginia Ferreira Chaves, Murillo Antunes, Juan Pablo Costabel, Armando Alves da Fonseca, Adriana Furtado, Juan Esteban Gomez-Mesa, Francisco Javier Marin Gutiérrez, Oren Caspi, Irina Maksimova, Manish Maski, Cecilia Micheletti, José Luiz Barros Pena, Márcia Gonçalves Ribeiro, Maria Juliana Rodríguez-González, Omac Tufekcioglu, Huseyin Onay","doi":"10.21037/cdt-23-191","DOIUrl":"10.21037/cdt-23-191","url":null,"abstract":"<p><strong>Background: </strong>Sarcomeric hypertrophic cardiomyopathy (HCM) must be differentiated from phenotypically similar conditions because clinical management and prognosis may greatly differ. Patients with unexplained left ventricular hypertrophy require an early, confirmed genetic diagnosis through diagnostic or predictive genetic testing. We tested the feasibility and practicality of the application of a 17-gene next-generation sequencing (NGS) panel to detect the most common genetic causes of HCM and HCM phenocopies, including treatable phenocopies, and report detection rates. Identification of transthyretin cardiac amyloidosis (ATTR-CA) and Fabry disease (FD) is essential because of the availability of disease-specific therapy. Early initiation of these treatments may lead to better clinical outcomes.</p><p><strong>Methods: </strong>In this international, multicenter, cross-sectional pilot study, peripheral dried blood spot samples from patients of cardiology clinics with an unexplained increased left ventricular wall thickness (LVWT) of ≥13 mm in one or more left ventricular myocardial segments (measured by imaging methods) were analyzed at a central laboratory. NGS included the detection of known splice regions and flanking regions of 17 genes using the Illumina NextSeq 500 and NovaSeq 6000 sequencing systems.</p><p><strong>Results: </strong>Samples for NGS screening were collected between May 2019 and October 2020 at cardiology clinics in Colombia, Brazil, Mexico, Turkey, Israel, and Saudi Arabia. Out of 535 samples, 128 (23.9%) samples tested positive for pathogenic/likely pathogenic genetic variants associated with HCM or HCM phenocopies with double pathogenic/likely pathogenic variants detected in four samples. Among the 132 (24.7%) detected variants, 115 (21.5%) variants were associated with HCM and 17 (3.2%) variants with HCM phenocopies. Variants in <i>MYH7</i> (n=60, 11.2%) and <i>MYBPC3</i> (n=41, 7.7%) were the most common HCM variants. The HCM phenocopy variants included variants in the <i>TTR</i> (n=7, 1.3%) and <i>GLA</i> (n=2, 0.4%) genes. The mean (standard deviation) ages of patients with HCM or HCM phenocopy variants, including <i>TTR</i> and <i>GLA</i> variants, were 42.8 (17.9), 54.6 (17.0), and 69.0 (1.4) years, respectively.</p><p><strong>Conclusions: </strong>The overall diagnostic yield of 24.7% indicates that the screening strategy effectively identified the most common forms of HCM and HCM phenocopies among geographically dispersed patients. The results underscore the importance of including ATTR-CA (<i>TTR</i> variants) and FD (<i>GLA</i> variants), which are treatable disorders, in the differential diagnosis of patients with increased LVWT of unknown etiology.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triglyceride levels and risk of cardiovascular disease and all-cause mortality in Chinese adults younger than 40 years old: a prospective cohort study. 40 岁以下中国成年人的甘油三酯水平与心血管疾病和全因死亡风险:一项前瞻性队列研究。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-03-29 DOI: 10.21037/cdt-23-412
Zhaogui Wu, Jingli Gao, Shuohua Chen, Guodong Wang, Hangkuan Liu, Xuezhu Wang, Pengfei Sun, Xuefang Yu, Qing Yang, Shouling Wu, Xin Zhou
{"title":"Triglyceride levels and risk of cardiovascular disease and all-cause mortality in Chinese adults younger than 40 years old: a prospective cohort study.","authors":"Zhaogui Wu, Jingli Gao, Shuohua Chen, Guodong Wang, Hangkuan Liu, Xuezhu Wang, Pengfei Sun, Xuefang Yu, Qing Yang, Shouling Wu, Xin Zhou","doi":"10.21037/cdt-23-412","DOIUrl":"10.21037/cdt-23-412","url":null,"abstract":"<p><strong>Background: </strong>Data on the associations of triglyceride (TG) levels with cardiovascular disease (CVD) and all-cause mortality mainly focused on the middle-aged or elderly population, with limited information available for younger adults. This study aimed to identify such associations among Chinese young adults.</p><p><strong>Methods: </strong>This study included Chinese adults younger than 40 years free of CVD, cancer, and lipid-lowering agents at baseline in the Kailuan study who were enrolled during 2006 through 2016. All participants were biennially followed up till December 2020. The enzymatic colorimetric method was used to measure baseline fasting TG. Participants were categorized into four groups by quartiles of TG, with the lowest quartile (Q1) as the reference group. The primary outcomes were CVD [composite of myocardial infarction (MI) and ischemic stroke] and all-cause mortality. CVD and mortality risks were estimated with Cox regression models.</p><p><strong>Results: </strong>A total of 43,882 participants were included. Their mean age was 30.6±5.56 years, and 80.2% were males. During a median follow-up of 11.2 years, 298 CVD events and 345 deaths occurred. The incidences of CVD and all-cause mortality were 0.67 and 0.76 per 1,000 person-years, respectively. Compared with individuals in the lowest quartile (Q1), participants in the highest quartile (Q4) showed a 126% higher risk of developing CVD [adjusted hazard ratio (HR) 2.26; 95% confidence interval (CI): 1.56 to 3.29; P=0.001] and a 61% higher risk of all-cause mortality (adjusted HR 1.61; 95% CI: 1.14 to 2.28; P=0.007). In addition, analyses of CVD subtypes showed that adjusted HRs (Q4 <i>vs.</i> Q1) were 3.25 (95% CI: 1.33 to 7.97; P=0.01) for MI, and 1.88 (95% CI: 1.16 to 3.04; P=0.01) for ischemic stroke.</p><p><strong>Conclusions: </strong>Among Chinese young adults, elevated fasting TG levels were associated with increased CVD and all-cause mortality risks.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the association between vascular remodeling and plaque calcification patterns of the carotid artery and its effects on ischemic symptoms using CT angiography. 使用 CT 血管造影术评估颈动脉血管重塑和斑块钙化模式之间的关联及其对缺血性症状的影响。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-04-16 DOI: 10.21037/cdt-23-428
Shanhu Xu, Jianjun Zhang, Jiahu Yang, Jianhua Mao, Baojie Mao, Qing Chen, Fengli Fu
{"title":"Evaluating the association between vascular remodeling and plaque calcification patterns of the carotid artery and its effects on ischemic symptoms using CT angiography.","authors":"Shanhu Xu, Jianjun Zhang, Jiahu Yang, Jianhua Mao, Baojie Mao, Qing Chen, Fengli Fu","doi":"10.21037/cdt-23-428","DOIUrl":"10.21037/cdt-23-428","url":null,"abstract":"<p><strong>Background: </strong>Arterial remodeling is a compensatory mechanism of the vessel wall in response to atherosclerotic plaque growth. However, the clinical significance of vascular remodeling of carotid lesions remains unclear. Through this study, we aimed to evaluate the association between vascular remodeling and ischemic symptoms in patients with an internal carotid artery (ICA) stenosis degree ≥50%, considering the differences in plaque calcification patterns.</p><p><strong>Methods: </strong>This retrospective cross-sectional study included adult patients with moderate-to-severe proximal ICA stenosis associated with atherosclerotic plaques admitted to the Zhejiang Hospital between September 2018 and March 2023. Parameters such as lumen diameter, plaque calcification types, calcium scores, and calcification thickness were assessed using non-contrast and contrast-enhanced computed tomography angiography (CTA). The remodeling ratio (RR) was calculated by dividing the maximum distance of the proximal ICA between the inner border of the arterial lumen at the plaque site and the outer borders of the plaque by the luminal diameter. Atherosclerosis risk factors and medications were recorded. The Mann-Whitney <i>U</i> test or chi-square test was used to compare the differences between groups. Correlations were measured using Pearson's correlation coefficient. Predictors of ischemic symptoms were assessed using multivariable logistic regression analysis, with results expressed as odds ratio (ORs) with 95% confidence intervals (CIs). A P value less than 0.05 (two-sided) was considered to indicate statistical significance The differences in RR among plaque calcification types and the association between vascular remodeling and clinical symptoms were analyzed.</p><p><strong>Results: </strong>A total of 242 ICAs in 196 patients were included in this study, and 84 were symptomatic and 158 were asymptomatic. The RR in symptomatic ICA [median, 1.31 (interquartile range, 1.17-1.68)] was significantly greater than that in asymptomatic group [median, 1.20 (interquartile range, 1.05-1.45)], P=0.006). Significant differences in RR existed among plaque calcification types, among which type 5 and 6 plaques had the highest RR. About 71.5% (173/242) of all ICAs showed positive remodeling. Significant correlations were observed between RR and ischemic symptoms and between positive remodeling and calcification thickness (P<0.05 for all variables). On multivariable logistic regression analysis, calcification thickness remained significantly associated with positive remodeling of carotid arteries (OR 2.30; 95% CI: 1.06-5.01; P=0.036).</p><p><strong>Conclusions: </strong>Arterial remodeling exists in the ICA. A significant association between arterial positive remodeling and plaque calcification thickness was established. RR helps predict ischemic symptoms. The results of our study suggest that arterial remodeling serves as a novel measure to help ascertain the ","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11071001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A proposal for a revision of the phlebographic classification of congenital venous malformations. 关于修订先天性静脉畸形静脉图分类的建议。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-04-01 DOI: 10.21037/cdt-23-378
Sarah M Bernhard, Franz R Kammer, Marie C Roumet, Fabian Haupt, Aleksandra Tuleja, Marc Schindewolf, Iris Baumgartner
{"title":"A proposal for a revision of the phlebographic classification of congenital venous malformations.","authors":"Sarah M Bernhard, Franz R Kammer, Marie C Roumet, Fabian Haupt, Aleksandra Tuleja, Marc Schindewolf, Iris Baumgartner","doi":"10.21037/cdt-23-378","DOIUrl":"10.21037/cdt-23-378","url":null,"abstract":"<p><strong>Background: </strong>Venous malformation (VM) is the most frequent type of congenital vascular malformation. In terms of functional outcome local sclerotherapy remains the most important therapeutic tool. For planning and correct estimation and prevention of complications, an exact anatomical classification of the VM is crucial. Not only the drainage, as assessed in the established classification, but also the phlebographic aspect of the internal VM structure itself plays a decisive role. In order to integrate this aspect, we aim to validate a proposal for a revised phlebographic VM classification distinguishing non-lacunar (a) and lacunar (b) types.</p><p><strong>Methods: </strong>We retrospectively analyzed all patients with VM in whom a direct puncture phlebography was performed in our clinic between 2009 and 2018 to assess morphology and flow characteristics. Phlebographic assessment included: (I) differentiation of non-lacunar <i>vs.</i> lacunar type; (II) drainage assignment according to the existing classification; (III) adjusted classification combining both. Inter-reader agreement was measured in percentage as well as by the Cohen's kappa coefficient (κ).</p><p><strong>Results: </strong>Overall 26 patients were classified as non-lacunar (a) and 41 patients as lacunar (b) VM. For this categorization, inter-reader agreement was 96% (κ=0.91). Classical Puig classification into types I, II, III and IV showed 87% inter-reader agreement (κ=0.78). For the adjusted classification adding the non-lacunar or lacunar characteristic to type I-IV an agreement of 82% (κ=0.77) was achieved.</p><p><strong>Conclusions: </strong>Phlebographic differentiation into non-lacunar and lacunar VM is feasible and reliable to distinguish phenotypic subgroups of patients with VM. We therefore propose to integrate this parameter of the internal VM structure into the existing classification.</p>","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of surgical aortic valve replacement volume on tamponade after transcatheter aortic valve replacement. 经导管主动脉瓣置换术后,手术主动脉瓣置换量对填塞的影响。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-04-19 DOI: 10.21037/cdt-23-467
Ankit Agrawal, Shashank Shekhar, Toshiaki Isogai, Shivabalan Kathavarayan Ramu, Osamah Badwan, James J Yun, Serge C Harb, Amar Krishnaswamy, Samir R Kapadia
{"title":"Impact of surgical aortic valve replacement volume on tamponade after transcatheter aortic valve replacement.","authors":"Ankit Agrawal, Shashank Shekhar, Toshiaki Isogai, Shivabalan Kathavarayan Ramu, Osamah Badwan, James J Yun, Serge C Harb, Amar Krishnaswamy, Samir R Kapadia","doi":"10.21037/cdt-23-467","DOIUrl":"10.21037/cdt-23-467","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid total arterial minimally invasive off-pump coronary revascularization and percutaneous coronary intervention strategy for multivessel coronary artery disease: a cohort study with a median 11-year follow-up. 多支血管冠状动脉疾病的混合全动脉微创离泵冠状动脉血运重建和经皮冠状动脉介入治疗策略:一项中位随访 11 年的队列研究。
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-04-30 Epub Date: 2024-04-18 DOI: 10.21037/cdt-23-413
Magdalena Rufa, Adrian Ursulescu, Ragi Nagib, Marc Albert, Ulrich F W Franke
{"title":"Hybrid total arterial minimally invasive off-pump coronary revascularization and percutaneous coronary intervention strategy for multivessel coronary artery disease: a cohort study with a median 11-year follow-up.","authors":"Magdalena Rufa, Adrian Ursulescu, Ragi Nagib, Marc Albert, Ulrich F W Franke","doi":"10.21037/cdt-23-413","DOIUrl":"10.21037/cdt-23-413","url":null,"abstract":"<p><strong>Background: </strong>Hybrid coronary revascularization (HCR) is a treatment approach that combines the benefits of coronary artery bypass grafting (CABG) techniques such as minimally invasive direct coronary artery bypass (MIDCAB) or minimally invasive multivessel CABG (MICS-CABG) with percutaneous coronary intervention (PCI) for carefully selected patients with multivessel coronary artery disease (MV CAD). The extant body of research primarily concentrates on the comparison of outcomes between HCR and CABG or PCI. Furthermore, HCR is defined primarily as MIDCAB and PCI. Given the various criteria for HCR identified in the current body of literature, as well as several hybrid revascularization techniques, our primary goal was to analyse the characteristics and track the development of HCR patients operated on in our centre (Robert Bosch Hospital) over both short and long periods of time. Additionally, we sought to validate the practical challenges that arise during the implementation of an HCR methodology.</p><p><strong>Methods: </strong>This cohort study included 138 patients with MV CAD who had an HCR approach in conjunction with isolated total arterial off-pump MICS-CABG or MIDCAB between 2007 and 2018 at Robert Bosch Hospital in Stuttgart. Data on major adverse cardiac and cerebral events (MACCE), defined as all-cause mortality, myocardial infarction, repeat revascularization and stroke were gathered through a questionnaire. Long-term follow-up, with a mean duration of 8.7±0.3 years and a median duration of 11 years, was available for a significant majority of the patients (92.8%, n=128).</p><p><strong>Results: </strong>The average age was 69.6±11.2 years, with 79% being male. The mean European System for Cardiac Operative Risk Evaluation score I additive (EuroSCORE I) additive was 7.6±10.2 and the mean SYNergy between PCI with TAXUS and Cardiac Surgery (SYNTAX) Score I was 22.9±9.4. A total of 97 MIDCAB surgeries and 41 MICS-CABG procedures were performed without any instances of conversion to sternotomy or cardiopulmonary bypass (CPB). A total of 70 patients, or 50.7% of the sample, received the planned PCI treatment. This percentage was substantially lower in the subgroup with chronic CAD, with just 27, equivalent to 39.1%. The observed 30-day death rate was 2.1% (3/138). During follow-up, 3 myocardial infarctions, 18 PCI repeats, no CABG, and 4 strokes occurred. From 128 followed-up patients, 28 died (21.9%), 7 of which were heart deaths (5.5%). Total MACCE was 36.7%. The survival rates at 3 and 5 years were 92% and 85% respectively. Patients who didn't get the planned PCI had a mean survival rate of 6.8-9.1 years, while those with completed hybrid treatment had a higher mean survival rate of 8.4-10.2 years.</p><p><strong>Conclusions: </strong>In selected individuals with MVCAD, current evidence suggests that HCR is a safe and effective coronary artery revascularization approach. After coronary bypass surgery, the attention goi","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11070998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of tissue factor pathway inhibitor on the pyroptosis of vascular smooth muscle cells induced by angiotensin II 组织因子通路抑制剂对血管紧张素 II 诱导的血管平滑肌细胞热解的影响
IF 2.4 3区 医学
Cardiovascular diagnosis and therapy Pub Date : 2024-02-01 DOI: 10.21037/cdt-23-355
Yue Dai, Rui Xu, Kelaier Yang, Tingting Jiang, Yongkang Wei, Yue Liu, Wenjia Chen, Yu Fu, Yong Zhao
{"title":"Effect of tissue factor pathway inhibitor on the pyroptosis of vascular smooth muscle cells induced by angiotensin II","authors":"Yue Dai, Rui Xu, Kelaier Yang, Tingting Jiang, Yongkang Wei, Yue Liu, Wenjia Chen, Yu Fu, Yong Zhao","doi":"10.21037/cdt-23-355","DOIUrl":"https://doi.org/10.21037/cdt-23-355","url":null,"abstract":"","PeriodicalId":9592,"journal":{"name":"Cardiovascular diagnosis and therapy","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139818551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信